Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angina II: Classification01:27

Angina II: Classification

422
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
422
Angina I: Introduction01:30

Angina I: Introduction

568
Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
568
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

277
Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
277
Angina V: Nursing Management01:20

Angina V: Nursing Management

358
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
358
Angina IV: Management01:26

Angina IV: Management

315
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
315
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

459
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
459

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial commentary: Polypills: Common garden variety or precision formulated for improving cardiovascular outcomes: An ongoing challenge.

Trends in cardiovascular medicine·2022
Same author

Effect of Obesity on Response to Spironolactone in Patients With Heart Failure With Preserved Ejection Fraction.

The American journal of cardiology·2021
Same author

Utilization of guideline-directed medical therapy in patients with de novo heart failure with reduced ejection fraction: A Veterans Affairs study.

Journal of family medicine and primary care·2020
Same author

Prognostic Value of 6-Minute Walk Distance in Patients Undergoing Percutaneous Coronary Intervention: a Veterans Affairs Prospective Study.

Texas Heart Institute journal·2020
Same author

Trimetazidine for stable and unstable ischemic heart diseases and for heart failure: Is its routine use justified from available data?

International journal of cardiology·2019
Same author

Trans fatty acids linked to myocardial infarction and stroke: What is the evidence?

Trends in cardiovascular medicine·2019

Related Experiment Video

Updated: Feb 17, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
06:39

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

16.8K

Chronic stable angina pectoris.

Udho Thadani, Asim Chohan

    Postgraduate Medicine
    |December 12, 2017
    PubMed
    Summary

    For stable angina pectoris, drug therapy is often effective. Revascularization is best for high-risk patients or those unresponsive to optimal antianginal agent treatment.

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Stable angina pectoris symptoms are manageable with medication in most cases.
    • Revascularization is typically reserved for specific patient subgroups.

    Purpose of the Study:

    • To guide the tailoring of medical therapy for stable angina.
    • To optimize treatment based on individual patient factors.

    Main Methods:

    • Review of current therapeutic strategies for stable angina.
    • Emphasis on risk stratification and patient response to antianginal agents.
    • Consideration of concomitant diseases in treatment planning.

    Main Results:

    • Optimal drug therapy controls symptoms in the majority of stable angina patients.

    More Related Videos

    Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
    07:59

    Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

    Published on: April 4, 2022

    1.8K
    A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
    18:11

    A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

    Published on: December 28, 2012

    24.8K

    Related Experiment Videos

    Last Updated: Feb 17, 2026

    Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
    06:39

    Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

    Published on: August 18, 2016

    16.8K
    Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
    07:59

    Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

    Published on: April 4, 2022

    1.8K
    A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
    18:11

    A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

    Published on: December 28, 2012

    24.8K
  • Revascularization is indicated for high-risk patients and non-responders to optimal medical therapy.
  • Personalized therapy considers comorbidities and individual drug responses.

    • Conclusions:

    • Tailoring antianginal drug therapy improves outcomes for stable angina patients.
    • Risk stratification and response assessment are crucial for treatment decisions.
    • A personalized approach to medical management is recommended.